ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Japanese drugmakers reduce Russia business in wake of Ukraine war

They join global peers in pulling back as logistics, payment systems deteriorate

Japan's Daiichi Sankyo has halted sales of some of its drugs to local distributors in Russia.

TOKYO -- Major Japanese pharmaceutical companies are reducing their business in Russia, joining their global peers in pulling back as the nation's invasion of Ukraine makes it tougher to operate there.

Daiichi Sankyo has halted sales of some of its drugs to local distributors in Russia, while Eiken Chemical has tentatively stopped supplying reagents used in blood tests for cancer.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more